1. Rusu-Nastase EG, Lupan AM, Marinescu CI et al. MiR-29a Increase in Aging May Function as a Compensatory Mechanism Against Cardiac Fibrosis Through SERPINH1 Downregulation. Front Cardiovasc Med. 2022 Jan 18;8:810241. doi: 10.3389/fcvm.2021.810241. 

​

2. Liehn EA, Lupan AM, Diaconu R et al. Heart function assessment during aging in apolipoprotein E knock-out mice. Discoveries (Craiova). 2021 Sep 28;9(3):e136. doi: 10.15190/d.2021.15. 

 

3. Neculachi CA, Neti LI, Burlacu A, Preda MB. Inflammation and Hypoxia Negatively Impact the Survival and Immunosuppressive Properties of Mesenchymal Stromal Cells In Vitro. Rom J Cardiol. 2021; 31 (3): 547. doi:10.47803/rjc.2021.31.3.547.

​

4. Marinescu CI, Preda MB, Neculachi CA et al. Identification of a hematopoietic cell population emerging from mouse bone marrow with proliferative potential in vitro and immunomodulatory capacity. Front. Immunol. 2021 Aug 3;12:698070. doi: 10.3389/fimmu.2021.698070

​

5. Lupan AM*, Rusu EG*, Preda MB et al. miRNAs generated from Meg3-Mirg locus are downregulated during aging. Aging (Albany NY). 2021 Jun 22;13(12):15875-15897. doi: 10.18632/aging.203208.

​

6. Marinescu CI, Preda MB, Burlacu A. A procedure for in vitro evaluation of the immunosuppressive effect of mouse mesenchymal stem cells on activated T cell proliferation. Stem Cell Res Ther. 2021 Jun 5;12(1):319. doi: 10.1186/s13287-021-02344-3.

​

7. Preda MB, Neculachi CA, Fenyo IM et al. Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice. Cell Death Dis. 2021 Jun 2;12(6):566. doi: 10.1038/s41419-021-03839-w.

​

8. Popescu S, Preda MB, Marinescu CI et al. Dual Stem Cell Therapy Improves the Myocardial Recovery Post-Infarction through Reciprocal Modulation of Cell Functions. Int J Mol Sci. 2021 May 26;22(11):5631. doi:10.3390/ijms22115631.